Clinical Trials Directory

Trials / Completed

CompletedNCT01053585

Structure and Function of the Gastro-esophageal Junction

Combined Magnetic Resonance Imaging and High Resolution Manometry Studies

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Aims of research project: To identify key features of the gastro-esophageal junction (structure and function) that protects the esophagus from gastro-esophageal reflux investigated by combined high resolution manometry and magnetic resonance imaging. Hypothesis: 1. Functional factors including GEJ function (e.g. sphincter pressure) and proximal gastric distension determine whether or not TLESR occurs; however 2. Structural factors including separation of GEJ anatomy, intra-gastric distribution of the meal and secretions determine whether TLESR is accompanied by no reflux event, gas reflux (belching) or reflux of ingested food and gastric secretion ('true reflux'). 3. Initial findings by descriptive studies in healthy volunteers (study #1) and patients with mild to moderate gastro-esophageal reflux disease (study #2) will be further interrogated by a randomized, double-blind control trial of baclofen in patients with GORD; a medication that inhibits reflux by effects on GOJ function (study #3) .

Conditions

Interventions

TypeNameDescription
DRUGBaclofenBaclofen suspension 40mg (single dose 90 minutes prior to physiologic measurement)
DRUGPlaceboPlacebo single 'dose' 90 minutes prior to study

Timeline

Start date
2007-02-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2010-01-21
Last updated
2011-06-02

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01053585. Inclusion in this directory is not an endorsement.